Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01145911 · ClinicalTrials.gov registry record
The Study of Ocular Hemodynamics With Glaucoma Progression
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 123
- Enrollment target
NCT01145911: Completed study, sponsored by Indiana University.
NCT01145911 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 123 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01145911 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 123 participants
- Enrollment target
Study Summary
To determine the relationships between ocular hemodynamics and glaucomatous optic neuropathy progression.
Primary Outcome
per visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2008-01 |
| Est. Completion | 2014-07-03 |
What the finished NCT01145911 record still lists
NCT01145911 is an observational study that tracks outcomes without assigning an intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01145911 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01145911 about?
NCT01145911 is a clinical study titled "The Study of Ocular Hemodynamics With Glaucoma Progression". To determine the relationships between ocular hemodynamics and glaucomatous optic neuropathy progression.
What is the current status of trial NCT01145911?
This trial is currently completed. The enrollment target is 123 participants. The study started on 2008-01. Estimated completion is 2014-07-03.
Who is sponsoring clinical trial NCT01145911?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia